JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265790

Human KDM1A (LSD1) knockout HeLa cell line

Human KDM1A (LSD1) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

KDM1A KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

別名を表示する

AOF2, Amine oxidase (flavin containing) domain 2, Amine oxidase, flavin containing, 2, BHC110, BRAF35-HDAC complex protein BHC110, BRAF35/HDAC complex, 110-kD subunit, CPRF, EC1, FAD-binding protein BRAF35-HDAC complex, 110 kDa subunit, Flavin-containing amine oxidase domain-containing protein 2, KDM 1, KDM1A_HUMAN, KIAA0601, LSD 1, Lysine (K) specific demethylase 1, Lysine (K) specific demethylase 1A, Lysine demethylase 1A, Lysine-specific demethylase 1, Lysine-specific demethylase 1A, Lysine-specific histone demethylase 1, Lysine-specific histone demethylase 1A

3 Images
Western blot - Human KDM1A (LSD1) knockout HeLa cell line (AB265790)
  • WB

Lab

Western blot - Human KDM1A (LSD1) knockout HeLa cell line (AB265790)

Lanes 1- 2 : Merged signal (red and green). Green - ab129195 observed at 110 kDa. Red - loading control ab8245 observed at 37 kDa.
ab129195 Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker was shown to specifically react with KDM1/LSD1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265790 (knockout cell lysate ab256965) was used. Wild-type and KDM1/LSD1 knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab129195 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker and ChIP Grade (<a href='/products/primary-antibodies/kdm1-lsd1-antibody-epr6825-nuclear-marker-and-chip-grade-ab129195'>ab129195</a>) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

KDM1A knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human KDM1A (LSD1) knockout HeLa cell line (ab265790)

Predicted band size: 155 kDa,92 kDa

Observed band size: 110 kDa,160 kDa

false

Western blot - Human KDM1A (LSD1) knockout HeLa cell line (AB265790)
  • WB

Lab

Western blot - Human KDM1A (LSD1) knockout HeLa cell line (AB265790)

Lanes 1- 2 : Merged signal (red and green). Green - ab69535 observed at 110 kDa. Red - loading control ab181602 observed at 37 kDa.
ab69535 Anti-KDM1/LSD1 antibody [1B2F2] was shown to specifically react with KDM1/LSD1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265790 (knockout cell lysate ab256965) was used. Wild-type and KDM1/LSD1 knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab69535 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-KDM1/LSD1 antibody [1B2F2] (<a href='/products/primary-antibodies/kdm1-lsd1-antibody-1b2f2-ab69535'>ab69535</a>)

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

KDM1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human KDM1A (LSD1) knockout HeLa cell line (ab265790)

Predicted band size: 92 kDa

Observed band size: 110 kDa

false

Sanger Sequencing - Human KDM1A (LSD1) knockout HeLa cell line (AB265790)
  • Sanger seq

Unknown

Sanger Sequencing - Human KDM1A (LSD1) knockout HeLa cell line (AB265790)

Homozygous : 4 bp deletion in exon 1.

Key facts

細胞タイプ

HeLa

生物種

Human

組織

Cervix

製品の状態

Liquid

form

ノックアウト検証方法

Sanger Sequencing,Western blot

ノックアウト変異

Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 1

抗生物質耐性

Puromycin 1µg/mL

疾病

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

製品の詳細

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

製品内容

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265790-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265790 Human KDM1A (LSD1) knockout HeLa cell line", "number":"AB265790-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265790-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265790-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265790 Human KDM1A (LSD1) knockout HeLa cell line", "number":"AB265790-CMP01", "productcode":"" } ] } } }

出荷温度及び保存条件

遺伝子名
KDM1A
遺伝子編集のタイプ
Knockout
遺伝子編集の方法
CRISPR technology
ノックアウト検証方法
Sanger Sequencing, Western blot
接合型
Homozygous
出荷温度
Dry Ice
短期保存温度
-196°C
長期保存温度
-196°C

取り扱い方法

初回取り扱いガイドライン

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

継代培養ガイドライン
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
培養培地

DMEM (High Glucose) + 10% FBS

凍結保存培地

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

製品プロトコール

ターゲットの情報

See full target information KDM1A

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com